Visual rating and volumetric measurement of medial temporal atrophy in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort: baseline diagnosis and the prediction of MCI outcome
- PMID: 24816477
- DOI: 10.1002/gps.4126
Visual rating and volumetric measurement of medial temporal atrophy in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort: baseline diagnosis and the prediction of MCI outcome
Abstract
Objective: This study aims to determine the clinical utility of visual ratings and volumetric measurements of medial temporal atrophy among subjects from the Alzheimer's Disease Neurorimaging Initiative (ADNI) cohort.
Methods: A sample of 189 subjects from the ADNI, Phase 1 (ADNI-1), was chosen as follows: 49 cognitively normal (CN), 89 with mild cognitive impairment (MCI), and 50 with Alzheimer's disease (AD). Structural MRI images were downloaded from the ADNI website, and a visual rating system (VRS) was used to obtain semi-quantitative ratings of the hippocampus (HPC) and entorhinal cortex (ERC). VRS ratings and FreeSurfer measures of the HPC and ERC were used to predict (i) baseline diagnosis and (ii) progression to AD among subjects with MCI at baseline.
Results: VRS and FreeSurfer measures of ERC were equivalent in classifying subjects at baseline, but FreeSurfer measures of HPC were superior to VRS measures for classifying CN versus MCI subjects. VRS and FreeSurfer measures of both HPC and ERC were significant predictors of progression from MCI to AD. However, VRS ratings of ERC were superior to other MRI measures. MCI subjects with minimal ERC atrophy by VRS had a threefold lower progression rate to AD at 3.2 years compared with those with mild, moderate, or severe atrophy (23% vs 63%, 69%, and 87%, respectively).
Conclusions: Visual ratings of HPC and ERC provide useful information to a physician in a clinical setting. Visual ratings of ERC may be especially useful in following patients with MCI.
Keywords: Alzheimer's; MCI; MRI; atrophy; entorhinal cortex; hippocampus.
Copyright © 2014 John Wiley & Sons, Ltd.
Similar articles
-
Visual rating system for assessing magnetic resonance images: a tool in the diagnosis of mild cognitive impairment and Alzheimer disease.J Comput Assist Tomogr. 2009 Jan-Feb;33(1):73-8. doi: 10.1097/RCT.0b013e31816373d8. J Comput Assist Tomogr. 2009. PMID: 19188789
-
Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.Cochrane Database Syst Rev. 2020 Mar 2;3(3):CD009628. doi: 10.1002/14651858.CD009628.pub2. Cochrane Database Syst Rev. 2020. PMID: 32119112 Free PMC article.
-
The utility of age-specific cut-offs for visual rating of medial temporal atrophy in classifying Alzheimer's disease, MCI and cognitively normal elderly subjects.Front Aging Neurosci. 2013 Sep 18;5:47. doi: 10.3389/fnagi.2013.00047. eCollection 2013. Front Aging Neurosci. 2013. PMID: 24065917 Free PMC article.
-
Volumetric and visual rating of magnetic resonance imaging scans in the diagnosis of amnestic mild cognitive impairment and Alzheimer's disease.Alzheimers Dement. 2011 Jul;7(4):e101-8. doi: 10.1016/j.jalz.2010.07.002. Alzheimers Dement. 2011. PMID: 21784342 Free PMC article.
-
Neuroimaging of hippocampal atrophy in early recognition of Alzheimer's disease--a critical appraisal after two decades of research.Psychiatry Res Neuroimaging. 2016 Jan 30;247:71-8. doi: 10.1016/j.pscychresns.2015.08.014. Psychiatry Res Neuroimaging. 2016. PMID: 26774855 Review.
Cited by
-
Use of Flutemetamol F 18-Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment.JAMA Neurol. 2018 Sep 1;75(9):1114-1123. doi: 10.1001/jamaneurol.2018.0894. JAMA Neurol. 2018. PMID: 29799984 Free PMC article.
-
A Clinically-Translatable Machine Learning Algorithm for the Prediction of Alzheimer's Disease Conversion in Individuals with Mild and Premild Cognitive Impairment.J Alzheimers Dis. 2018;61(4):1555-1573. doi: 10.3233/JAD-170547. J Alzheimers Dis. 2018. PMID: 29355115 Free PMC article.
-
Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer's disease: Validation in a large memory clinic population.Eur Radiol. 2017 Aug;27(8):3147-3155. doi: 10.1007/s00330-016-4726-3. Epub 2017 Jan 12. Eur Radiol. 2017. PMID: 28083697 Free PMC article.
-
Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.Alzheimers Dement. 2017 Apr;13(4):e1-e85. doi: 10.1016/j.jalz.2016.11.007. Epub 2017 Mar 22. Alzheimers Dement. 2017. PMID: 28342697 Free PMC article. Review.
-
Association of Homocysteine Levels With Medial Temporal Lobe Atrophy Among Carriers and Non-carriers of APOE ε4 in MCI Subjects.Front Psychiatry. 2022 Apr 12;13:823605. doi: 10.3389/fpsyt.2022.823605. eCollection 2022. Front Psychiatry. 2022. PMID: 35492717 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical